Skip to main content
. 2022 Nov 24;55:101757. doi: 10.1016/j.eclinm.2022.101757

Table 1.

Risk of major outcomes according to the adherence to the ABC pathway (n = 24,608).

Outcome Number of criteria
0-1 vs. 2–3 criteria
Full vs. incomplete adherence
0 criteria (n = 707)
(Ref.)
1 criteria (n = 5285)
aHR [95% CI]a
2 criteria (n = 12,112)
aHR [95% CI]a
3 criteria (n = 6504)
aHR [95% CI]a
0-1 criteria (n = 5992)
(Ref.)
2-3 criteria (n = 18,616)
aHR [95%CI]a
Incomplete adherence (n = 18,104)
(Ref.)
Full adherence (n = 6504)
aHR [95%CI]a
Primary outcome
 All-cause death and MACE Ref. 0.69 [0.57–0.84] 0.58 [0.48–0.70] 0.54 [0.44–0.67] Ref. 0.79 [0.72–0.86] Ref. 0.87 [0.79–0.97]
Secondary outcomes
 All-cause death Ref. 0.73 [0.58–0.92] 0.61 [0.49–0.76] 0.58 [0.46–0.74] Ref. 0.79 [0.72–0.87] Ref. 0.89 [0.79–1.00]
 CV death Ref. 0.62 [0.45–0.87] 0.46 [0.33–0.65] 0.44 [0.30–0.64] Ref. 0.69 [0.59–0.82] Ref. 0.84 [0.68–1.04]
 Stroke Ref. 0.71 [0.47–1.08] 0.63 [0.42–0.95] 0.51 [0.33–0.79] Ref. 0.81 [0.67–0.97] Ref. 0.77 [0.62–0.95]
 Thromboembolism Ref. 0.74 [0.51–1.07] 0.65 [0.46–0.93] 0.54 [0.37–0.79] Ref. 0.81 [0.69–0.95] Ref. 0.78 [0.65–0.94]
 MACE Ref. 0.64 [0.50–0.82] 0.52 [0.40–0.66] 0.46 [0.35–0.60] Ref. 0.74 [0.66–0.84] Ref. 0.82 [0.71–0.95]
 Myocardial infarction Ref. 0.69 [0.43–1.11] 0.59[0.37–0.93] 0.64 [0.38–1.06] Ref. 0.82 [0.65–1.03] Ref. 1.01 [0.77–1.33]
 Major bleeding Ref. 1.01 [0.63–1.61] 1.10 [0.70–1.74] 1.11 [0.69–1.78] Ref. 1.10 [0.92–1.31] Ref. 1.04 [0.87–1.24]
 All-cause death, stroke, and major bleeding Ref. 0.78 [0.64–0.96] 0.69 [0.57–0.85] 0.67 [0.54–0.82] Ref. 0.86 [0.79–0.93] Ref. 0.92 [0.83–1.01]
 All-cause death, MACE, and major bleeding Ref. 0.75 [0.62–0.91] 0.67 [0.56–0.80] 0.64 [0.53–0.78] Ref. 0.85 [0.78–0.92] Ref. 0.92 [0.83–1.01]

Bold text depicts statistically significant results at p < 0.05 level.

aHR = adjusted hazard ratio; CI = confidence interval; CV = cardiovascular; MACE = major adverse cardiovascular events; Ref. = Reference group.

a

Adjusted for age, sex, type of atrial fibrillation, hypertension, diabetes mellitus, chronic heart failure, coronary artery disease, peripheral artery disease, history of stroke/transient ischemic attack.